Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses
- PMID: 11683583
- PMCID: PMC3342689
- DOI: 10.1006/clim.2001.5109
Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses
Abstract
Acute infection with equine infectious anemia virus (EIAV), a lentivirus of horses, results in a persistent high-level viremia in Arabian foals affected with severe combined immunodeficiency (SCID). This observation argues against the idea that the transient nature of acute lentiviral viremia is solely a function of viral population dynamics. To extend these studies, EIAV-specific immune reconstitution was attempted prior to EIAV challenge in two SCID foals, using adoptively transferred virus-stimulated lymphocytes derived from persistently EIAV-infected half sibling donors. Following transfer, lymphocyte engraftment occurred in one foal, and EIAV-specific cytotoxic T lymphocytes as well as neutralizing antibody activity developed. Following a brief period of plasma viremia in this foal, EIAV replication was controlled and plasma virus could not be detected by RT-PCR or culture. These results provide further direct evidence that a specific immune response is required for termination of plasma viremia in acute lentiviral infections.
Copyright 2001 Academic Press.
Figures





Similar articles
-
Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.J Virol. 2011 Jul;85(13):6814-8. doi: 10.1128/JVI.00077-11. Epub 2011 May 4. J Virol. 2011. PMID: 21543497 Free PMC article.
-
Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.J Virol. 2004 Sep;78(17):9295-305. doi: 10.1128/JVI.78.17.9295-9305.2004. J Virol. 2004. PMID: 15308724 Free PMC article.
-
Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy.Vet Immunol Immunopathol. 2008 Jan 15;121(1-2):8-22. doi: 10.1016/j.vetimm.2007.07.011. Epub 2007 Jul 25. Vet Immunol Immunopathol. 2008. PMID: 17727961 Free PMC article.
-
Cytotoxic T lymphocytes in protection against equine infectious anemia virus.Anim Health Res Rev. 2004 Dec;5(2):271-6. doi: 10.1079/ahr200482. Anim Health Res Rev. 2004. PMID: 15984338 Review.
-
Immunopathogenesis of equine infectious anemia lentivirus disease.Dev Biol Stand. 1990;72:31-7. Dev Biol Stand. 1990. PMID: 2178127 Review.
Cited by
-
Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2.Vet Immunol Immunopathol. 2007 Jul 15;118(1-2):121-8. doi: 10.1016/j.vetimm.2007.04.001. Epub 2007 Apr 8. Vet Immunol Immunopathol. 2007. PMID: 17498813 Free PMC article.
-
Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.Vaccine. 2009 Apr 21;27(18):2453-68. doi: 10.1016/j.vaccine.2009.02.048. Epub 2009 Feb 24. Vaccine. 2009. PMID: 19368787 Free PMC article.
-
CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.Virology. 2004 Sep 15;327(1):144-54. doi: 10.1016/j.virol.2004.06.035. Virology. 2004. PMID: 15327905 Free PMC article.
-
Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus.Vaccines (Basel). 2014 May 27;2(2):397-421. doi: 10.3390/vaccines2020397. Vaccines (Basel). 2014. PMID: 26344625 Free PMC article.
-
Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.J Virol. 2011 Jul;85(13):6814-8. doi: 10.1128/JVI.00077-11. Epub 2011 May 4. J Virol. 2011. PMID: 21543497 Free PMC article.
References
-
- Letvin NL, Schmitz JE, Jordan HL, Seth A, Hirsch VM, Reimann KA, Kuroda MJ. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus. Immunological Reviews. 1999;170:127–34. 127–134. - PubMed
-
- Phillips AN. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science. 1996;271:497–499. - PubMed
-
- Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999;283:857–860. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources